FindTrial
Sign In

Pregnancy outcome in early severe alloimmunised pregnancies

Outcome in early severe alloimmunised pregnancies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/11/016405
Enrollment
40
Registered
2018-11-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O360- Maternal care for rhesus isoimmunization

Interventions

None listed

Sponsors

Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Rh alloimmunized fetus with severe anemia requiring intrauterine blood transfusion. Severe fetal anemia will be diagnosed if fetal PCV is less than or equal to 30%

Exclusion criteria

Exclusion criteria: Patients with major congenital defect in fetus not compatible with life

Design outcomes

Primary

MeasureTime frame
Abortion , still birth, neonatal death Perinatal survival Neonatal ComplicationsTimepoint: Abortion , still birth, neonatal death Perinatal survival Neonatal Complications—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactKamaldeep Bains

Post graduate institute of medical education and research, Chandigarh

drscsaha@gmail.com7087009353

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026